Michael Skynner
Director Técnico/Científico/I+D en BICYCLE THERAPEUTICS PLC .
Fortuna: 2 M $ al 30/04/2024
Cargos activos de Michael Skynner
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BICYCLE THERAPEUTICS PLC | Director Técnico/Científico/I+D | 03/01/2022 | - |
Director de Operaciones | 01/01/2018 | 03/01/2022 | |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | Director de Operaciones | 01/01/2018 | - |
Historial de carrera de Michael Skynner
Antiguos cargos conocidos de Michael Skynner.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 01/09/2013 | 01/01/2016 |
Cambridge Biotechnology Ltd.
Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Biotechnology Ltd. is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class 'gene to lead' drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area. CBT is always looking to identify potential partner companies for both in-licensing and risk-sharing drug discovery ventures. | Fundador | 01/05/2001 | 01/05/2005 |
Formación de Michael Skynner.
Imperial College London | Doctorate Degree |
Estadísticas
Internacional
Reino Unido | 4 |
Estados Unidos | 3 |
Operativa
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
BICYCLE THERAPEUTICS PLC | Health Technology |
PFIZER, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Cambridge Biotechnology Ltd.
Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Biotechnology Ltd. is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class 'gene to lead' drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area. CBT is always looking to identify potential partner companies for both in-licensing and risk-sharing drug discovery ventures. | Commercial Services |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Skynner
- Experiencia